Conflicts of Interest May Have Cost Sharpless FDA Nomination
WASHINGTON – After a turbulent run as acting commissioner of the Food and Drug Administration (FDA), Ned Sharpless will be ... Read More
FDA
Three Questions Trump’s Expected FDA Pick Must Answer
Stephen Hahn’s history in healthcare industry leaves open questions of ethics and priorities WASHINGTON – President Trump is expected to announce ... Read More